Skip to main content
OpenTrials
Completed

NCT Number: NCT02078128

To Study the Effect of β-glucans on Wound Healing

The purpose of this study is to determine the effect of β-glucans on wound healing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

National Taiwan University Hospital

Taipei, 100, Taiwan

About this study

The structure of βeta-glucan (β-glucans) is a pathogen associated molecular patterns (pathogen-associated molecular patterns, PAMPs), widely present in the cell walls of plants, bacteria, yeasts, fungi, mushrooms and algae. Modern has been reported in the literature that β-glucan can enhance the immune system of animals, and to enhance the function of the animal against bacterial, fungal and viral infections, and cancer.In this study, the use of β-glucan to enhance the biological characteristics of the non-specific immunity, to explore the impact of postoperative patients with wound healing and infection rates.The observation of the healing process to take the Leather District wounds (5 ~ 200 cm2). The experiments were carried out for 18 months, were observed record the following three: (1) the rate of wound healing, (2) The rate of infection assessment: record length of time and the point in time at all levels of antibiotic use also observe the wound change (redness, swelling, heat, pain).(3) days of hospitalization, and spend statistics. Using unpaired student's t-test analysis, group data whether the differences between groups of experimental data. represents a statistically significant when p <0.05.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Total burn area under 20%, two to three degree burn and need skin-grafting.
  • Subjects don't have other diseases.
  • Subjects' age between 20 to 60.

Exclusion criteria

  • Subjects with hypersensitivity.
  • Subjects with Autoimmune disease.

Treatment and study plan

oral beta-glucans

Dietary Supplement

30 mg/kg, oral every day until wound healed completes or unacceptable toxicity develops.

Other names: D-glucose polysaccharides

oral sugar powder

Drug

30 mg/kg, oral every day until wound healed completes or unacceptable toxicity develops.

Other names: placebo, sugar, glucose

Primary outcomes

  1. Wound healing percentage

    Time frame: every Monday and Thuresday for the duration of hospital stay, an expected average of 3 weeks

    record data by taking picture

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2013
First posted
Mar 5, 2014
Registry last updated
Mar 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.